Skip to content
Open access

Janibacter melonis bone marrow infection in an immunocompetent child with prolonged fever of unknown origin: a case report

Aug 2026 · BMC Infectious Diseases · 0 citations

TL;DR

This case expands the known clinical spectrum of J. melonis to include deep-seated bone marrow infection in immunocompetent children, and suggests that combination therapy with linezolid and trimethoprim-sulfamethoxazole may be a reasonable treatment option, although further evidence is required to define the optimal regimen.

Abstract

Janibacter melonis ( J. melonis ) is a rare environmental actinomycete with only three previously reported human infections, all presenting as bacteraemia — all in adults, two of whom were immunocompetent and one of whom had refractory diffuse large B-cell lymphoma. Bone marrow involvement in an immunocompetent paediatric host has not been described. A previously healthy 13-year-old girl presented with prolonged fever of unknown origin following an initial pneumonia-like illness. After extensive non-invasive investigations failed to identify an aetiological agent, bone marrow aspiration and culture identified J. melonis . She was successfully treated with a combination of intravenous linezolid and trimethoprim-sulfamethoxazole, achieving microbiological clearance by day 20 and sustained clinical remission at three-month follow-up. This case expands the known clinical spectrum of J. melonis to include deep-seated bone marrow infection in immunocompetent children, and suggests that combination therapy with linezolid and trimethoprim-sulfamethoxazole may be a reasonable treatment option, although further evidence is required to define the optimal regimen. In selected clinical scenarios — such as when initial blood cultures remain negative or when advanced molecular diagnostics (e.g., metagenomic next-generation sequencing) are declined by the patient’s family — bone marrow puncture with extended culture incubation may be considered, particularly when infection by slow-growing or fastidious organisms is suspected. Prolonging the incubation period beyond the standard timeframe may enhance the recovery of rare and fastidious pathogens.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.